Experience with hormone receptors in renal cancer

I. Romics, Ch Rüssel, D. Bach

Research output: Contribution to journalArticle

Abstract

The hormone receptor concentrations in tumour tissues from 20 renal carcinoma patients were determined before postoperative medroxyprogesterone acetate (MPA) therapy was started. Except for glucocorticoid receptors, the concentrations were either not measureable or were extremely low. The question is whether MPA therapy, solely on the strength of its character as a general roborant, is still useful in the treatment of renal tumours, even when it fails to exercise primary influence because of the absence of suitable receptors. None of the 20 patients was treated with MPA.

Original languageEnglish
Pages (from-to)507-512
Number of pages6
JournalInternational Urology and Nephrology
Volume22
Issue number6
DOIs
Publication statusPublished - Nov 1990

Fingerprint

Medroxyprogesterone Acetate
Kidney Neoplasms
Hormones
Kidney
Glucocorticoid Receptors
Neoplasms
Therapeutics
Exercise
Carcinoma

ASJC Scopus subject areas

  • Urology
  • Nephrology
  • Geriatrics and Gerontology

Cite this

Experience with hormone receptors in renal cancer. / Romics, I.; Rüssel, Ch; Bach, D.

In: International Urology and Nephrology, Vol. 22, No. 6, 11.1990, p. 507-512.

Research output: Contribution to journalArticle

@article{37161399c7b84cd4b227d919f6561efe,
title = "Experience with hormone receptors in renal cancer",
abstract = "The hormone receptor concentrations in tumour tissues from 20 renal carcinoma patients were determined before postoperative medroxyprogesterone acetate (MPA) therapy was started. Except for glucocorticoid receptors, the concentrations were either not measureable or were extremely low. The question is whether MPA therapy, solely on the strength of its character as a general roborant, is still useful in the treatment of renal tumours, even when it fails to exercise primary influence because of the absence of suitable receptors. None of the 20 patients was treated with MPA.",
author = "I. Romics and Ch R{\"u}ssel and D. Bach",
year = "1990",
month = "11",
doi = "10.1007/BF02549737",
language = "English",
volume = "22",
pages = "507--512",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Experience with hormone receptors in renal cancer

AU - Romics, I.

AU - Rüssel, Ch

AU - Bach, D.

PY - 1990/11

Y1 - 1990/11

N2 - The hormone receptor concentrations in tumour tissues from 20 renal carcinoma patients were determined before postoperative medroxyprogesterone acetate (MPA) therapy was started. Except for glucocorticoid receptors, the concentrations were either not measureable or were extremely low. The question is whether MPA therapy, solely on the strength of its character as a general roborant, is still useful in the treatment of renal tumours, even when it fails to exercise primary influence because of the absence of suitable receptors. None of the 20 patients was treated with MPA.

AB - The hormone receptor concentrations in tumour tissues from 20 renal carcinoma patients were determined before postoperative medroxyprogesterone acetate (MPA) therapy was started. Except for glucocorticoid receptors, the concentrations were either not measureable or were extremely low. The question is whether MPA therapy, solely on the strength of its character as a general roborant, is still useful in the treatment of renal tumours, even when it fails to exercise primary influence because of the absence of suitable receptors. None of the 20 patients was treated with MPA.

UR - http://www.scopus.com/inward/record.url?scp=0025683150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025683150&partnerID=8YFLogxK

U2 - 10.1007/BF02549737

DO - 10.1007/BF02549737

M3 - Article

VL - 22

SP - 507

EP - 512

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 6

ER -